Diaceutics PLC

Investor Overview


At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Diagnostic Network solution for the development and commercialization of precision medicine diagnostics. 


The Company, quoted on the AIM Market of the London Stock Exchange has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500+ labs in 51 countries.

Financial Calendar

2020

6 Month End
30th Jun
Year End
31st Dec

2021

Final Results
15th Mar
Date of AGM
30th Apr
Half Year Results
30th Jun

Have a question?

The Diaceutics Investment Case

Interim Report June 2020

Governance & Sustainability

Financial Calendar

2020

6 Month End
30th Jun
Year End
31st Dec

2021

Final Results
15th Mar
Date of AGM
30th Apr
Half Year Results
30th Jun

The Diaceutics Investment Case

Interim Report June 2020

Have a question?

Governance & Sustainability

Investor Alerts

If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.